Comparing the HPV status regarding the oncomine assay, we found CCND1, CDK6, and EGFR amplifications only in HPV-negative cases, while PIK3CA amplifications and mutations were only found in HPV-positive HNSCC (Figure 2). This evidence concerns the gene CDK6 and head and neck squamous cell carcinoma.